Skip to content
OpenCapital
Get started
Income StatementBalance SheetCash FlowSegments
Moderna logo

Moderna Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Moderna holds $11.5B in total assets. Shareholders' equity is $7.4B against $1.3B in total debt. Cash and equivalents total $1.9B. The current ratio is 2.41 and debt-to-equity is 0.179. Based on the Q1 2026 filing.

Total Assets$11.5BTotal Stockholders Equity$7.4BLong Term Debt$590.0MCash And Equivalents$1.9BTotal Current Assets$5.8BTotal Current Liabilities$2.4B
Latest FilingQ1 2026
Report Date2026-05-01
Market Cap$19.7B
ROE-36.56%

Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts payable$405M$226M$175M$267M$317M$161M
Accrued Contingent Liabilities—————$950M
Accrued expenses$221M$120M$197M$310M$420M$108M
Accrued Manufacturing Costs$312M$120M$197M$310M$420M$108M
Accrued Progress Collections and Price Adjustments$58M$58M$65M$157M$153M$154M
Accrued Royalties (Current)$46M$5M$6M$42M$31M$967M
Other Commercial Liabilities$1.4B$1B$987M$1.2B$1.4B$1.9B
Contract liabilities$58M$58M$65M$157M$153M$154M
Contract Liabilities and Refund Liability$370M$337M$308M$426M$509M$470M
Accrued Liabilities, Current$1.4B$1B$987M$1.2B$1.4B$1.9B
Compensation and benefits$312M$120M$197M$310M$420M$108M
Other accrued liabilities$221M$252M$192M$73M$185M$220M
Current portion of long-term debt$23M$28M$27M$31M$25M$31M
Deferred revenue$153M$125M$218M$163M$99M$102M
Finance Lease Liability, Current$23M———$25M—
Finance Lease Liability Payment Due—$67M$63M$60M—$46M
Finance Lease Liability - Undiscounted Excess Amount—$4M$4M$3M—$2M
Lease Liability Payments - 2020 (Remaining Three Months)—$47M$29M$12M—$47M
Lease Liability Payments - 2021—$24M$27M$26M—$20M
Operating Lease Liability Payments - 2024 (Lessee)—$77M$78M$78M—$81M
Operating Lease Liability Payments - 2025 (Lessee)—$82M$82M$82M—$80M
Lease Liability Payments - Due Year Two—$18M$20M$20M—$0
Lease Liability Payments - Due Year Three—$80M$81M$81M—$82M
Lease Liability Payments - Due Year Four—$82M$82M$82M—$80M
Lease Liability Payments - Remainder of Fiscal Year—$25M$16M$14M—$26M
Operating lease liabilities, current$14M$15M$16M$17M$17M$19M
Operating Lease Liability Payments Due—$1.1B$1.1B$1.1B—$1B
Operating Lease Liability - Undiscounted Excess Amount—$433M$423M$409M—$383M
Other current liabilities$23M$30M$31M$25M$16M$59M
Total current liabilities$2.2B$1.6B$1.6B$1.7B$2B$2.4B

Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts receivable, net$358M$78M$36M$1B$184M$71M
Available-for-Sale Debt Securities - Amortized Cost$5.1B$4.4B$3.9B$3.4B$3.2B$3.3B
Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year)$5.1B$4.4B$3.9B$3.4B$3.2B$3.3B
Available-for-Sale Debt Securities - Fair Value by Maturity$7.6B$6.8B$6.2B$5.5B$5.5B$5.5B
Available-for-Sale Debt Securities - Single Maturity Date$7.6B$6.8B$6.2B$5.5B$5.5B$5.5B
Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months)$22M$11M$7M$5M$3M$2M
AFS and Trading Securities - Unrealized Loss Position (>=12 Months)$22M$11M$7M$5M$3M$2M
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value$6M$2M$2M$0$1M$9M
Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months)$6M$2M$2M$0$1M$9M
Available-for-Sale Debt Securities - Unrealized Loss Position$4.3B$3.1B$2.6B$1.4B$1.2B$3.9B
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value$22M$11M$7M$5M$3M$2M
AFS and Trading Securities - Unrealized Loss Position Fair Value$28M$13M$9M$5M$4M$11M
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value$6M$2M$2M$0$1M$9M
Allowance for Doubtful Accounts$0—$12M$3M$3M$6M
Allowance for Doubtful Accounts Receivable (Current)$0—$12M$3M$3M$6M
Cash and cash equivalents$1.9B$1.6B$1.3B$1.1B$2.6B$1.9B
Cash, Cash Equivalents, and Marketable Securities$28M$13M$9M$5M$4M$11M
Available For Sale Securities Debt Securities Current$5.1B$4.4B$3.9B$3.4B$3.2B$3.3B
Finished goods$28M$14M$45M$128M$33M$14M
Other current assets$38M$69M$57M$56M$45M$51M
Accrued investment income$59M$53M$47M$40M$42M$39M
Trading assets$5.1B$4.4B$3.9B$3.4B$3.2B$3.3B
Income taxes receivable$28M$33M$40M$41M$41M$35M
Finished goods$28M$14M$45M$128M$33M$14M
Raw materials$63M$75M$83M$85M$91M$94M
Work in process$26M$39M$112M$119M$29M$38M
Inventories$150M$134M$127M$115M$114M$117M
Prepaid expenses and other current assets$599M$585M$764M$716M$408M$348M
Prepaid Tax$45M$45M$31M$35M$37M$29M
Restricted cash—$1M$1M$1M—$0
Short-term investments$5.1B$4.4B$3.9B$3.4B$3.2B$3.3B
Total current assets$8.1B$6.8B$6.2B$6.6B$6.5B$5.8B

Equity

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Additional paid-in capital$866M$982M$1.1B$1.3B$1.4B$1.5B
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss$2.6B$1.4B$567M$499M$283M$271M
Accumulated other comprehensive income (loss)-$10M$10M$23M$27M$45M$25M
Common stock01.6B1.6B1.6B1.6B1.6B
Common Stock Par Value Per Share$0.00$0.00$0.00$0.00$0.00$0.00
Common Stock Shares Issued386M387M389M391M394M397M
Convertible Preferred Stock Authorized Shares162M162M162M162M162M162M
Convertible Preferred Stock Issued Shares000000
Convertible Preferred Stock Outstanding Shares000000
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March&#160;31, 2026 and December&#160;31, 2025, respectively$0$0$0$0$0$0
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding$0$0$0$0$0$0
Investments - Gross Unrealized Losses$28M$13M$9M$5M$4M$11M
Preferred stock$0$0$0$0$0$0
Preferred Stock Par Value Per Share$0.00$0.00$0.00$0.00$0.00$0.00
Retained earnings$10B$9.1B$8.2B$8B$7.2B$5.9B
Share-Based Payment - Unrecognized Cost of Nonvested Awards—$1.1B$908M$770M—$978M
Total liabilities and stockholders' equity$14.1B$12.7B$12B$12.1B$12.3B$11.5B
Total stockholders' equity$10.9B$10.1B$9.4B$9.3B$8.7B$7.4B

Non-Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years)$2.5B$2.4B$2.4B$2.1B$2.3B$2.3B
Allowance for credit losses$0$0$0$0$0$0
Deferred Tax Assets and Other Non-Current Assets$594M$556M$546M$530M$605M$675M
Available-for-sale securities$2.5B$2.4B$2.4B$2.1B$2.3B$2.3B
Goodwill$52M$52M$52M$52M$52M$52M
Intangible assets, net$40M$49M$48M$47M$45M$116M
Investments - Amortized Cost Basis$7.6B$6.8B$6.2B$5.5B$5.5B$5.6B
Net Investment in Lease$759M$752M$750M$738M$719M$706M
Long-term marketable securities$2.5B$2.4B$2.4B$2.1B$2.3B$2.3B
Deferred tax assets$81M$81M$81M$81M$81M$82M
Intangible assets &#8212; net$40M$49M$48M$47M$45M$116M
Operating lease right-of-use assets$759M$752M$750M$738M$719M$706M
Other non-current assets$594M$556M$546M$530M$605M$675M
Property, plant and equipment, net$2.2B$2.2B$2.2B$2.1B$2.1B$2.1B
Operating lease right-of-use assets$759M$752M$750M$738M$719M$706M
Operating Lease Right-of-Use Assets in Other Assets$759M$752M$750M$738M$719M$706M
Other non-current assets$21M$16M$22M$22M$52M$50M
Accumulated depreciation$527M$566M$623M$671M$737M$794M
Total property and equipment, gross$2.7B$2.8B$2.8B$2.8B$2.9B$2.9B
Property and equipment, net$2.2B$2.2B$2.2B$2.1B$2.1B$2.1B
Software and Technology Licenses, Net$594M$556M$546M$530M$605M$675M
Total assets$14.1B$12.7B$12B$12.1B$12.3B$11.5B

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Components252.00180.00140.00103.00108.00292.00
Cumulative Cost Basis$7.6B$6.8B$6.2B$5.5B$5.5B$5.6B
Accounts Receivable, Chargebacks, Discounts And Fees$340M-$171M$212M$975M$181M$126M
Accounts Receivable, after Allowance for Credit Loss$358M$78M$36M$1B$184M$71M
Clinical trials$94M$88M$38M$30M$20M$46M
Commercial$45M$24M$24M$21M$23M$16M
Development operations$120M$120M$108M$94M$106M$81M
Manufacturing$109M$128M$152M$113M$140M$79M
Other external goods and services$131M$82M$63M$53M$57M$82M
Property, plant and equipment$99M$49M$47M$31M$45M$31M
Licensing Arrangements$46M$5M$6M$42M$31M$967M
Accounts Receivable, Allowance for Credit Loss$0—$12M$3M$3M$6M
Total$7.6B$6.8B$6.2B$5.5B$5.5B$5.6B
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five$2.5B$2.4B$2.4B$2.1B$2.3B$2.3B
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five$2.5B$2.4B$2.4B$2.1B$2.3B$2.3B
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One$5.1B$4.4B$3.9B$3.4B$3.2B$3.3B
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One$5.1B$4.4B$3.9B$3.4B$3.2B$3.3B
Collaboration receivable$58M$26M$20M$9M$13M$1M
Common stock, par value (in dollars per share)$0$0$0$0$0$0
Common stock, shares authorized (in shares)$1.6B$1.6B$1.6B$1.6B$1.6B$1.6B
Common stock, shares issued (in shares)$386M$387M$389M$391M$394M$397M
Common Stock, Shares, Outstanding$386M$387M$389M$391M$394M$397M
Contract with Customer, Liability$211M$183M$283M$320M$252M$256M
Accrued sales returns$370M$337M$308M$426M$509M$470M
Debt Securities, Available-for-Sale, Allowance for Credit Loss$0$0$0$0$0$0
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss$2.6B$1.4B$567M$499M$283M$271M
Less than 12 months$6M$2M$2M$0$1M$9M
12 months or more$22M$11M$7M$5M$3M$2M
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss$1.7B$1.8B$2B$869M$931M$3.6B
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss$4.3B$3.1B$2.6B$1.4B$1.2B$3.9B
Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions$252$180$140$103$108$292
Debt Securities, Available-for-Sale, Unrealized Loss Position$28M$13M$9M$5M$4M$11M
Deferred income taxes$231M$234M$237M$239M$249M$253M
Down payments and prepayments, non-current$139M$119M$111M$105M$100M$97M
Unrecognized compensation cost related to non-vested awards—$1.1B$908M$770M—$978M
Current maturities of long-term debt$23M$28M$27M$31M$25M$31M
Finance Lease Liability Payments Due—$67M$63M$60M—$46M
2027—$24M$27M$26M—$20M
Finance Lease Liability Payments Due Year Four—$0$0$0—$0
Finance Lease Liability Payments Due Year Three—$0$0$0—$0
Finance Lease Liability Payments Due Year Two—$18M$20M$20M—$0
Thereafter—$0$0$0—$0
Finance Lease Liability Undiscounted Excess Amount—$4M$4M$3M—$2M
Finance Lease, Right-of-Use Asset, after Accumulated Amortization$65M$59M$53M$47M$42M$36M
Research and development funding receivable (Note 5)$0—$191M$195M$0$7M
Income Taxes Receivable Noncurrent$97M$99M$99M$99M$161M$161M
Interest receivable on interest rate and cross currency swaps$59M$53M$47M$40M$42M$39M
Loss on future firm purchase commitments$60M$20M$14M$12M$5M$5M
Lessee Operating Lease Liability Payments Due—$1.1B$1.1B$1.1B—$1B
Thereafter—$757M$762M$760M—$679M
Lessee Operating Lease Liability Undiscounted Excess Amount—$433M$423M$409M—$383M
Loss Contingency Accrual—————$950M
Number of development candidates—31.0030.0030.00—25.00
Number of development programs—41.0039.0040.00—35.00
Operating And Finance Lease, Liability$747M$745M$741M$734M$715M$708M
Operating And Finance Lease, Liability, Current$37M$43M$43M$48M$42M$50M
Operating And Finance Lease, Liability, Noncurrent$710M$702M$698M$686M$673M$658M
Operating And Finance Lease, Right-Of-Use Asset$824M$811M$803M$785M$761M$742M
Down payments and prepayments related to manufacturing and materials$106M$84M$96M$77M$61M$55M
Other$23M$30M$31M$25M$16M$59M
Other$36M$40M$39M$42M$36M$30M
Preferred Stock, Par or Stated Value Per Share$0$0$0$0$0$0
Preferred Stock, Shares Authorized$162M$162M$162M$162M$162M$162M
Preferred Stock, Shares Issued$0$0$0$0$0$0
Preferred Stock, Shares Outstanding$0$0$0$0$0$0
Raw materials$41M$28M$30M$46M$30M$27M
Estimated reimbursements to wholesalers and distributors$103M$179M$118M$0$84M$111M
Research and development funding liability (Note 5)$58M$0$0$0$43M$0
Remainder of Fiscal Year 2024—$47M$29M$12M—$47M

Non-Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Contract Liabilities, Non-Current$58M$58M$65M$157M$153M$154M
Finance lease liabilities$39M$35M$32M$26M$20M$13M
Finance Lease Liabilities (Total)$62M$63M$59M$57M$45M$44M
Operating Lease Liability Payments - 2027 (Lessee)—$80M$81M$81M—$82M
Operating Lease Liability Payments - 2028 (Lessee)—$82M$82M$82M—$80M
Long-term debt$0———$590M$590M
Deferred revenue, net of current portion$58M$58M$65M$157M$153M$154M
Operating lease liabilities, non-current$671M$667M$666M$660M$653M$645M
Operating Lease Liabilities (Total)$685M$682M$682M$677M$670M$664M
Other non-current liabilities$267M$274M$276M$281M$285M$283M
Total liabilities$3.2B$2.6B$2.6B$2.8B$3.7B$4.1B